May 03, 2019
WELLESLEY, Mass., May 3, 2019–Growing genomic and proteomic research and strengthening industry-academia research collaborations are helping to drive the global electrophoresis market, according to a report by BCC Research, “Electrophoresis Technology: Global Markets.”
The market expects to see a compound annual growth rate (CAGR) of 6% through 2023, when it could be worth $2.7 billion.
Major players in the market include Thermo Fisher (TMO), Bio-Rad (BIO), PerkinElmer (PKI), Lonza Biosciences (LONN), and GE Healthcare (GE).
Research Highlights
“The global market landscape is composed of both multinational and regional market participants, with North America and Europe dominating the market,” notes report author Andrew McWilliams. “The growth of the Asia-Pacific market in recent years made this market lucrative for multinational instrument companies to expand their presence in the developing nations.”
Emerging Technologies Include Bufferless Gel Chips, Smart CE Systems
A number of technology developments are likely to impact the market in coming years. In 2018, an article in a scientific journal described the development of a bufferless gel electrophoresis chip, which consists of a precast agarose gel confined in a disposable plastic body with electrodes. In 2017, Thermo Fisher Scientific introduced a new cartridge-based capillary electrophoresis system geared for researchers seeking low-throughput Sanger sequencing and fragment analysis.
Editors/reporters requesting analyst interviews should contact Sarah Greenberg at press@bccresearch.com.
Electrophoresis Technology: Global Markets( MST040E )
Publish Date: Apr 2019
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.